Exai Bio
Pre-clinicalEX MARKS THE SPOT, AI CRACKS THE CODE. Exai is harnessing RNA for early, accurate cancer detection and profound insights from just a blood sample.
Founded
2020
Focus
Diagnostics
About
EX MARKS THE SPOT, AI CRACKS THE CODE. Exai is harnessing RNA for early, accurate cancer detection and profound insights from just a blood sample.
Funding History
2Total raised: $77.5M
Series A$67.5MKhosla VenturesJan 15, 2022
Seed$10MKhosla VenturesJan 15, 2020
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile